KRAS and colorectal carcinoma: We also examined apoptotic responses to Everolimus in isogenic CRC cell lines with WT or mutant KRAS (G13D or G12V) [22, 23], and mutant KRAS appears less well associated with apoptosis resistance (Figure S1A).